ZBH

Q: What is the price of Zimmer Biomet (ZBH) today?

The price of Zimmer Biomet (ZBH) today is $ 100.99, with return of -2.79% compared to the last year. The price of Zimmer Biomet (ZBH) started the year trading around $ 89.92 and today it is at $ 100.99. Follow the real-time price chart, the historical price of Zimmer Biomet (ZBH) and international markets.

Q: When does Zimmer Biomet (ZBH) pay dividends?

In the last year, Zimmer Biomet (ZBH) distributed dividends in the month of January, totaling $ 0.24. The Dividend Yield for the last 12 months is 0.97%.

Q: Is Zimmer Biomet (ZBH) worth it?

Currently, Zimmer Biomet (ZBH) is priced at $ 100.99, with a P/E of 27.59%, representing a deviation of 3,435% from its historical average P/E. In the last year, the stock showed a variation of -2.79 in its price and distributed $ 0.24 in dividends, resulting in a Dividend Yield of 0.97%. The total shareholder return was -2.79%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Zimmer Biomet (ZBH) stock?

Investing in stocks of Zimmer Biomet (ZBH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Zimmer Biomet (ZBH) yield today?

The yield of Zimmer Biomet (ZBH) was 17.76% in the last month, -2.79% in the last year and -33.64% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.96 in dividends, with a Dividend Yield of 0.97%.If you wanted to buy 100 stocks of Zimmer Biomet (ZBH) today, the total investment would be $ 10,099.00, based on the current price of $ 100.99.If past performance were to repeat, the return on your investment would be:In 1 year: $ 9,817.24In 5 years: $ 6,701.70In 10 years: $ 11,705.75It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Zimmer Biomet Holdings Inc.

Price

$ 100.99

return (12m)

-2.79%

p/e

27.59

p/b

1.53

DIVIDEND YIELD

0.97%

price ZBH

ZBH

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of ZBH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

17.76%

3 months

3.83%

1 year

-2.79%

2 years

-18.60%

5 years

-33.64%

10 years

15.91%

Fundamentals ZBH

review the fundamentals of Zimmer Biomet shares

P/E

27.59

Sector: -2.14 Industry: 0.05

P/S (Price-to-Sales)

2.36

Sector: 2.06 Industry: 2.57

P/B

1.53

Sector: 2.34 Industry: 2.50

DIVIDEND YIELD (DY)

0.97%

Sector: - Industry: -

ROA

3.05%

Sector: -27.16% Industry: -25.38%

ROE

5.55%

Sector: -30.98% Industry: -31.44%

ROIC

5.09%

Sector: -421.19% Industry: -78.34%

NET MARGIN

8.56%

Sector: -29.07% Industry: -29.80%

GROSS MARGIN

69.71%

Sector: 44.34% Industry: 50.68%

OPERATING MARGIN

16.48%

Sector: -24.62% Industry: -25.92%

EV/EBITDA

8.77

Sector: -0.57 Industry: 1.13

EV/EBIT

17.31

Sector: -2.98 Industry: -1.31

PRICE-TO-ASSETS

0.84

Sector: 1.23 Industry: 1.34

BVPS

64.50

Sector: 3.47 Industry: 4.81

EPS

3.58

Sector: -0.90 Industry: -0.87

EQUITY-TO-ASSETS RATIO

0.55

Sector: 0.42 Industry: 0.44

LIABILITIES / ASSETS

0.45

Sector: 0.46 Industry: 0.51

CAGR REVENUE 5 YEARS

0.99%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

11.91%

Sector: - Industry: -

FAIR VALUE OF Zimmer Biomet ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 100.99

Fair Value

$ 0.00

Upside Return potential.

-28.63%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ZBH

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
LLY	43.78	37.88	86.53%	0.59%	$ 903.52 B	31.66%
ISRG	62.65	9.97	15.92%	0.00%	$ 178.94 B	28.38%
TMO	28.66	3.59	12.52%	0.34%	$ 192.11 B	15.05%
SNY	12.51	1.36	10.86%	4.73%	$ 114.14 B	18.68%
NVS	21.85	6.56	30.04%	2.43%	$ 305.57 B	24.67%
ABT	29.61	3.77	12.73%	2.12%	$ 193.15 B	14.72%
MDT	26.07	2.58	9.90%	2.92%	$ 124.17 B	13.71%
GSK	15.56	5.56	35.71%	2.82%	$ 118.68 B	17.48%
CVS	55.09	1.29	2.35%	3.47%	$ 97.40 B	0.44%
BSX	38.16	0.00	0.00%	0.00%	$ 110.60 B	14.44%
TMDX	49.74	12.85	25.84%	0.00%	$ 4.56 B	16.20%
HCA	17.89	-43.80	-244.82%	0.54%	$ 121.36 B	8.97%
IDXX	48.00	31.68	65.99%	0.00%	$ 50.85 B	24.62%
RMD	25.46	5.99	23.51%	0.87%	$ 37.83 B	27.53%
DHR	40.98	2.82	6.88%	0.61%	$ 148.12 B	14.71%
INMD	10.22	1.40	13.73%	0.00%	$ 958.86 M	25.32%
FMS	17.45	0.87	5.00%	3.23%	$ 14.24 B	3.73%
PHG	27.73	2.24	8.06%	2.93%	$ 28.76 B	5.07%
SYK	44.76	6.48	14.48%	0.90%	$ 145.29 B	12.92%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ZBH Historical Dividends

current DY: 0.97%

5-year average DY: 0.85%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	12/30/2025	01/30/2026	0,24000000
Dividend	09/30/2025	10/31/2025	0,24000000
Dividend	06/26/2025	07/31/2025	0,24000000
Dividend	03/31/2025	04/30/2025	0,24000000
Dividend	12/30/2024	01/31/2025	0,24000000
Dividend	09/30/2024	10/31/2024	0,24000000
Dividend	06/26/2024	07/31/2024	0,24000000
Dividend	03/29/2024	04/30/2024	0,24000000
Dividend	12/27/2023	01/31/2024	0,24000000
Dividend	09/29/2023	10/31/2023	0,24000000
Dividend	06/26/2023	07/31/2023	0,24000000
Dividend	03/29/2023	04/28/2023	0,24000000
Dividend	12/27/2022	01/31/2023	0,24000000
Dividend	09/30/2022	10/31/2022	0,24000000
Dividend	06/27/2022	07/29/2022	0,24000000
Dividend	03/29/2022	04/29/2022	0,24000000
Dividend	12/28/2021	01/31/2022	0,23300971
Dividend	09/30/2021	10/29/2021	0,23300971
Dividend	06/28/2021	07/30/2021	0,23300971
Dividend	03/29/2021	04/30/2021	0,23300971
Dividend	12/28/2020	01/29/2021	0,23300971
Dividend	09/30/2020	10/30/2020	0,23300971
Dividend	06/29/2020	07/31/2020	0,23300971
Dividend	03/27/2020	04/30/2020	0,23300971
Dividend	12/27/2019	01/31/2020	0,23300971
Dividend	09/30/2019	10/31/2019	0,23300971
Dividend	06/28/2019	07/31/2019	0,23300971
Dividend	03/29/2019	04/30/2019	0,23300971
Dividend	12/28/2018	01/31/2019	0,23300971
Dividend	09/28/2018	10/31/2018	0,23300971
Dividend	06/29/2018	07/31/2018	0,23300971
Dividend	03/29/2018	04/30/2018	0,23300971
Dividend	12/29/2017	01/29/2018	0,23300971
Dividend	09/22/2017	10/27/2017	0,23300971
Dividend	06/23/2017	07/28/2017	0,23300971
Dividend	03/31/2017	04/28/2017	0,23300971
Dividend	12/30/2016	01/27/2017	0,23300971
Dividend	09/23/2016	10/28/2016	0,23300971
Dividend	06/24/2016	07/29/2016	0,23300971
Dividend	03/31/2016	04/29/2016	0,23300971
Dividend	12/31/2015	01/29/2016	0,21359223
Dividend	09/30/2015	10/30/2015	0,21359223
Dividend	05/15/2015	07/14/2015	0,21359223
Dividend	03/06/2015	04/24/2015	0,21359223
Dividend	12/29/2014	01/30/2015	0,21359223
Dividend	09/26/2014	10/31/2014	0,21359223
Dividend	06/27/2014	07/25/2014	0,21359223
Dividend	03/28/2014	04/25/2014	0,21359223
Dividend	12/27/2013	01/31/2014	0,19417476
Dividend	09/27/2013	10/25/2013	0,19417476
Dividend	06/28/2013	07/26/2013	0,19417476
Dividend	03/28/2013	04/26/2013	0,19417476
Dividend	12/27/2012	01/25/2013	0,17475728
Dividend	09/27/2012	10/26/2012	0,17475728
Dividend	06/28/2012	07/27/2012	0,17475728
Dividend	03/30/2012	04/27/2012	0,17475728

ABOUT THE COMPANY Zimmer Biomet

Zimmer Biomet Holdings Inc.

Average user rating I10

4.0 (1 people)

United States

25 years

Founded: 2001

2001

Time since IPO - 25 years

19.900

Employees

Additional Information

The Company Zimmer Biomet Holdings Inc. (United States), is listed on NYSE with a market value of $ 19.45 Billions, having an equity of $ 12.71 Billions.

With a total of 19.900 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 8.23 Billions, which generated a profit in the amount of $ 705.00 Millions.

As for its main indicators, the Company has a P/E ratio of 27.59, a P/BV ratio of 1.53 and in the last 12 months the dividend yield of ZBH was at 0.97%.

The Company is traded internationally through the ticker ZBH.

Market cap

$ 19.45 Billions

Net worth

$ 12.71 Billions

US$ 12,705,800,000.00

Assets

$ 23.09 Billions

US$ 23,091,700,000.00

Total Shares Outstanding

197.00 Millions

197,000,000

Average Daily Trading Volume

$ 2.25 Millions

US$ 2,254,408.80

Sector

Health

Industry

Medical Supplies and Equipment

ZBH

ZBH revenue and profits

Financial Results ZBH

DRAG THE FRAME TO SEE MORE DATA

ZBH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/B

0.00

CVS - CVS Health

$ 78.01 25,60% (12M)

P/E

55.09

3.47%

ROE

2.35%

P/B

1.29

CI - Cigna

$ 288.82 --2,15% (12M)

P/E

10.85

2.15%

ROE

0.00%

P/B

0.00

CNC - Centene

$ 42.93 --26,22% (12M)

P/E

-3.19

0.00%

ROE

-33.28%

P/B

1.06

HUM - Humana

$ 186.83 --27,20% (12M)

P/E

17.64

1.86%

ROE

6.95%

P/B

1.23

HCA - HCA Healthcare

$ 525.88 65,35% (12M)

P/E

17.89

0.54%

ROE

-244.82%

P/B

-43.80

LLY - Eli Lilly

$ 1,022.02 12,02% (12M)

P/E

43.78

0.59%

ROE

86.53%

P/B

37.88

NVS - Novartis

$ 165.53 60,51% (12M)

P/E

21.85

2.43%

ROE

30.04%

P/B

6.56